Dr. Lal Path Labs Ltd. has informed the Exchange about Copy of Newspaper Publication
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal PathLabs has informed the stock exchanges that it published its unaudited financial results for the quarter and half year ended September 30, 2025 in two newspapers — Financial Express and Jansatta — on November 1, 2025. This submission is being made under SEBI Listing Regulations (Regulations 30 and 47), which require listed companies to publish their quarterly results in newspapers. The company has attached copies of these newspaper advertisements to the filing for the exchanges' records. The actual financial numbers are not detailed in this particular filing, as the Q2 results would have been filed separately with the exchanges. The communication is signed by Vinay Gujral, Company Secretary & Compliance Officer.
This is a routine regulatory compliance filing with no new material information for shareholders. Investors looking for the actual Q2 FY26 numbers should refer to the detailed financial results filed earlier under Regulation 33 of SEBI LODR. The stock price is unlikely to be affected by this specific disclosure.